Prazosin H-3

Details

Stereochemistry	ACHIRAL
Molecular Formula	C19H21N5O4
Molecular Weight	385.4092
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[3H]C1=CC=C(O1)C(=O)N2CCN(CC2)C3=NC4=CC(OC)=C(OC)C=C4C(N)=N3

InChI

InChIKey=IENZQIKPVFGBNW-FIRFLZKJSA-N

InChI=1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22)/i9T

HIDE SMILES / InChI

Molecular Formula	C19H21N5O4
Molecular Weight	385.4092
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Wed Apr 02 16:29:38 GMT 2025` Edited by `admin` on `Wed Apr 02 16:29:38 GMT 2025`
Record UNII	6QZ7XLY9SJ
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

[3H]Prazosin

Preferred Name

English

Prazosin H-3

Common Name

English

Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanyl-5-t-carbonyl)-

Systematic Name

English

Code System Code Type Description

FDA UNII

6QZ7XLY9SJ

Created by admin on Wed Apr 02 16:29:38 GMT 2025 , Edited by admin on Wed Apr 02 16:29:38 GMT 2025

PRIMARY

CAS

785739-09-5

Created by admin on Wed Apr 02 16:29:38 GMT 2025 , Edited by admin on Wed Apr 02 16:29:38 GMT 2025

PRIMARY

PUBCHEM

169490745

Created by admin on Wed Apr 02 16:29:38 GMT 2025 , Edited by admin on Wed Apr 02 16:29:38 GMT 2025

PRIMARY

Related Record Type Details


					Q7A4S7HOP4

ALPHA-1B ADRENERGIC RECEPTOR

TARGET->LIGAND

Comments:

Binding assay

Qualification:

Kd

Amount:


					XM03YJ541D

PRAZOSIN

NON-LABELED -> LABELED

Amount:


					P5O3A2DHB2

ALPHA-1D ADRENERGIC RECEPTOR

TARGET->LIGAND

Comments:

Binding Assay

Qualification:

Kd

Amount:


					3T7136LE8K

ALPHA-1A ADRENERGIC RECEPTOR

TARGET->RADIOLIGAND

Interaction Type:

BINDING

Qualification:

Kd

Amount: